Key result
Cyclosporin A substantially attenuated compensatory myocardial hypertrophy in rats with congestive heart failure (P<0.05), but led to increased left ventricular dilatation and reduced cardiac function.
Why the study?
Does cyclosporin A inhibit myocardial hypertrophy and affect cardiac remodeling in rats with postinfarction congestive heart failure?
Population
Rats with congestive heart failure (CHF) induced by left coronary artery ligation
Comparison
Cyclosporin A (CsA) for 14 days vs Vehicle for 14 days
Design
Preclinical, randomized
Follow-up
14 days
Authors
Loading...
Calcineurin inhibition may blunt compensatory hypertrophy but worsen remodeling in experimental HF; leaves open human relevance.
RCT
randomized
Does cyclosporin A inhibit myocardial hypertrophy and affect cardiac remodeling in rats with postinfarction congestive heart failure?
p-value: p=<0.05
Inhibition of calcineurin by cyclosporin A attenuates compensatory myocardial hypertrophy but aggravates cardiac dysfunction and remodeling after myocardial infarction in rats.
Øie et al. (2000) conducted an RCT in Congestive heart failure (CHF) post-myocardial infarction. Cyclosporin A (CsA) vs. Vehicle was evaluated on Myocardial hypertrophy assessed by ventricular weight-to-tibial length ratios (p=<0.05). Cyclosporin A substantially attenuated compensatory myocardial hypertrophy in rats with congestive heart failure (P<0.05), but led to increased left ventricular dilatation and reduced cardiac function.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: